Pharma News
FDA Approves Tevimbra, BeiGene’s Treatment for Adults with Unresectable or Metastatic Esophageal Squamous Carcinoma
![](https://meefro.com/wp-content/uploads/2024/03/FDA-Approves-Tevimbra-BeiGenes-Treatment-for-Adults-with-Unresectable-or-780x470.png)
Tevimbra (tislelizumab-jsgr) has been approved as a monotherapy for adult patients with unresectable or metastatic esophageal squamous cell carcinoma who have previously undergone systemic chemotherapy excluding PD-L1 inhibitors.
Source link
#FDA #Approves #Tevimbra #BeiGenes #Treatment #Adults #Unresectable #Metastatic #Esophageal #Squamous #Carcinoma